xbrl.rienks.biz
Unilever N.V.
| Address | Exchange | Stocks (08-09-2010: 17:38:00) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Industry: Consumer Goods
Sector: Food Products
Food producers, including meatpacking, snacks, fruits, vegetables, dairy products and frozen seafood. Includes producers of pet food and manufacturers of dietary supplements, vitamins and related items. Excludes producers of fruit juices, tea, coffee, bottled water and other nonalcoholic beverages, which are classified under Soft Drinks.
| Alanheri N.V. | (ALANH) | Food Products |
| Amsterdam Commodities N.V. | (ACOMO) | Food Products |
| CSM N.V. | (CSM) | Food Products |
| Koninklijke Numico N.V. | (NUM) | Food Products |
| Unilever N.V. | (UNA) | Food Products |
| Koninklijke Wessanen N.V. | (WES) | Food Products |
| English | Dutch | |
| Annual Report 2007 (1.12 MB) (PricewaterhouseC) Annual Report 2006 (1.26 MB) (PricewaterhouseC) Annual Report 2005 (0.85 MB) (PricewaterhouseC) Annual Report 2004 (1.97 MB) (PricewaterhouseC) Annual Report 2003 (1.39 MB) (PricewaterhouseC) Annual Report 2002 (2.33 MB) (PricewaterhouseC) Annual Report 2001 (1.41 MB) (PricewaterhouseC) Annual Report 2000 (0.55 MB) (PricewaterhouseC) | Jaarverslag 2007 (1.03 MB) (PricewaterhouseC) Jaarverslag 2006 (1.35 MB) (PricewaterhouseC) Jaarverslag 2005 (0.94 MB) (PricewaterhouseC) Jaarverslag 2004 (1.88 MB) (PricewaterhouseC) Jaarverslag 2003 (1.31 MB) (PricewaterhouseC) Jaarverslag 2002 (2.36 MB) (PricewaterhouseC) Jaarverslag 2001 (1.46 MB) (PricewaterhouseC) |
News
| FDA warns Unilever and Dr Pepper on Green Tea wording (07 Sep)
The Food and Drug Administration has warned beverage makers Dr Pepper Snapple Group Inc and Unilever for making improper statements regarding green tea on product labels and web sites... Solazyme Adds Unilever as Strategic Investor (08 Sep)SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. the leading industrial biotechnology company producing renewable oil and bioproducts from microalgae, announced that Unilever has joined its Series D financing round as a strategic investor. The strategic investment by Unilever adds to the previously announced Series D round. This strategic investment leverages the development ..... The Daily Dose: Weight Loss Can Be Toxic, But Obesity Is Expensive (08 Sep)FDA Takes On Green Tea: Dr Pepper Snapple Group's Canada Dry and Unilever's Lipton are in hot water for overextended health claims on labels and promotional websites for their green tea products, reports the Los Angeles Times. Canada Dry Sparkling Green Tea Ginger Ale features the tagline, "enhanced with antioxidants." The soda is classified – [...].. | FDA Warns Tea Drink Makers About Unsubstantiated Claims (08 Sep)
Ever heard of tea-flavored beverage makers making health claims for their teas which really should only be made for properly brewed tea? It seems the FDA (Food and Drug Administration, USA) has, and is warning both Dr. Pepper Snapple Group about its Canada Dry Sparkling Green Tea Ginger Ale and Unilever Americas over its website claims and labeling for Lipton Green Tea. It accuses them of making ..... Channel 4’s Andy Duncan joins luxury car dealership (07 Sep)Former Channel 4 chief executive and Unilever marketer Andy Duncan has signed up to take the same title at luxury car dealership HR Owen... Ex-Channel 4 boss becomes HR Owen chief exec (07 Sep)Prior to his career in broadcasting, Duncan worked for Unilever for 17 years. Duncan is used to being well paid and he may not have as a high a salary as in recent years. Duncan was paid £1.48m by Channel 4 in 2009, although that includes £731,000 in lieu of notice... |
Financial Calendar
| Yearly result | Quaterly Results | Analyst & Investor Conference |
|---|---|---|
| 08-02-2006 | Q1 - | - |
| Q2 - | - | |
| AGM | Q3 - | - |
| - | Q4 - | - |
Annual Accounts Unilever N.V.
| 2004-12-31 | 2005-12-31 | 2006-12-31 | CHANGE | |
|---|---|---|---|---|
|
| ||||
| Figures in 1.000 x EUR | ||||
| Balance Sheet (Presentation) | ||||
| Assets (Presentation) | ||||
| Assets, Non-Current (Presentation) | ||||
| Property, Plant and Equipment, Net | 6.181.000 | 6.492.000 | 6.276.000 | -3,33% |
| Intangible Assets, Net | 17.007.000 | 18.055.000 | 17.206.000 | -4,70% |
| Investments in Subsidiaries, at Cost | 698.000 | 0,00% | ||
| Investments in Associates, at Cost | 54.000 | 17.000 | 46.000 | 170,59% |
| Investments in Joint Ventures, at Cost | 67.000 | 57.000 | -14,93% | |
| Deferred Tax Assets | 1.491.000 | 1.703.000 | 1.266.000 | -25,66% |
| Trade and Other Receivables, Net, Non-Current | 279.000 | 231.000 | 252.000 | 9,09% |
| Prepayments, Non-Current | 625.000 | 1.036.000 | 1.697.000 | 63,80% |
| Other Assets, Non-Current | 33.000 | 757.000 | 771.000 | 1,85% |
| Assets, Non-Current, Total | 26.368.000 | 28.358.000 | 27.571.000 | -2,78% |
| Assets, Current (Presentation) | ||||
| Non-Current Assets and Disposal Groups Held for Sale | 217.000 | 14.000 | -93,55% | |
| Inventories | 3.756.000 | 4.107.000 | 3.796.000 | -7,57% |
| Other Financial Assets, Current | 1.013.000 | 335.000 | 237.000 | -29,25% |
| Current Tax Receivables | 125.000 | 0,00% | ||
| Trade and Other Receivables, Net, Current | 4.131.000 | 4.830.000 | 4.290.000 | -11,18% |
| Cash and Cash Equivalents | 1.590.000 | 1.529.000 | 1.039.000 | -32,05% |
| Assets, Current, Total | 10.490.000 | 11.018.000 | 9.501.000 | -13,77% |
| Assets, Total | 36.858.000 | 39.376.000 | 37.072.000 | -5,85% |
| Equity and Liabilities (Presentation) | ||||
| Equity (Presentation) | ||||
| Equity Attributable to Equity Holders of Parent (Presentation) | ||||
| Issued Capital | 2.172.000 | 674.000 | 649.000 | -3,71% |
| Other Reserves | -2.555.000 | -2.328.000 | -2.143.000 | -7,95% |
| Retained Earnings (Accumulated Losses) | 7.647.000 | 10.015.000 | 12.724.000 | 27,05% |
| Equity Attributable to Equity Holders of Parent | 7.264.000 | 8.361.000 | 11.230.000 | 34,31% |
| Minority Interest | 365.000 | 404.000 | 442.000 | 9,41% |
| Equity, Total | 7.629.000 | 8.765.000 | 11.672.000 | 33,17% |
| Liabilities (Presentation) | ||||
| Liabilities, Non-Current (Presentation) | ||||
| Interest-Bearing Borrowings, Non-Current | 6.893.000 | 6.457.000 | 4.239.000 | -34,35% |
| Provisions, Non-Current | 565.000 | 732.000 | 826.000 | 12,84% |
| Post-Employment Benefit Obligation, Non-Current | 6.079.000 | 6.617.000 | 4.777.000 | -27,81% |
| Deferred Tax Liabilities | 1.067.000 | 1.146.000 | 1.275.000 | 11,26% |
| Trade and Other Payables, Non-Current | 439.000 | 389.000 | 399.000 | 2,57% |
| Liabilities, Non-Current, Total | 15.043.000 | 15.341.000 | 11.516.000 | -24,93% |
| Liabilities, Current (Presentation) | ||||
| Liabilities Included in Disposal Groups Classified as Held for Sale | 26.000 | -100,00% | ||
| Interest-Bearing Borrowings, Current | 5.155.000 | 5.942.000 | 4.362.000 | -26,59% |
| Provisions, Current | 799.000 | 644.000 | 1.009.000 | 56,68% |
| Current Tax Payables | 718.000 | 430.000 | 579.000 | 34,65% |
| Trade and Other Payables, Current | 7.514.000 | 8.228.000 | 7.934.000 | -3,57% |
| Liabilities, Current, Total | 14.186.000 | 15.270.000 | 13.884.000 | -9,08% |
| Liabilities, Total | 29.229.000 | 30.611.000 | 25.400.000 | -17,02% |
| Equity and Liabilities, Total | 36.858.000 | 39.376.000 | 37.072.000 | -5,85% |
|
|
2004 | 2005 | 2006 | |
| Figures in 1.000 x EUR | ||||
| Income Statement (Presentation) | ||||
| Profit (Loss) from Operations (Presentation) | ||||
| Revenue (Presentation) | ||||
| Revenue, Total | 37.168.000 | 38.401.000 | 39.642.000 | 3,23% |
| Other Operating Income (Presentation) | ||||
| Operating Expenses (Presentation) | ||||
| Operating Expenses, Total | 33.187.000 | 33.327.000 | 34.234.000 | 2,72% |
| Profit (Loss) from Operations | 3.981.000 | 5.074.000 | 5.408.000 | 6,58% |
| Profit (Loss) Before Tax (Presentation) | ||||
| Finance Costs [for Non-Financial Activities] | 623.000 | 613.000 | 721.000 | 17,62% |
| Income (Loss) from Investments | 54.000 | 33.000 | 30.000 | -9,09% |
| Share of Profit (Loss) from Equity-Accounted Investments | 41.000 | 22.000 | 114.000 | 418,18% |
| Share of Profit (Loss) from Equity-Accounted Associates | 2.000 | -25.000 | 36.000 | -244,00% |
| Share of Profit (Loss) from Equity-Accounted Joint Ventures | 39.000 | 47.000 | 78.000 | 65,96% |
| Profit (Loss) Before Tax | 3.453.000 | 4.516.000 | 4.831.000 | 6,98% |
| Profit (Loss) After Tax from Continuing Operations (Presentation) | ||||
| Income Tax Expense (Income) | 725.000 | 1.181.000 | 1.146.000 | -2,96% |
| Profit (Loss) After Tax from Continuing Operations | 2.728.000 | 3.335.000 | 3.685.000 | 10,49% |
| Profit (Loss) (Presentation) | ||||
| Profit (Loss) from Discontinued Operations, Net of Tax | 213.000 | 640.000 | 1.330.000 | 107,81% |
| Profit (Loss) | 2.941.000 | 3.975.000 | 5.015.000 | 26,16% |
| Profit (Loss) Attributable to Equity Holders of Parent and Minority Interest (Presentation) | ||||
| Profit (Loss) Attributable to Equity Holders of Parent | 2.755.000 | 3.766.000 | 4.745.000 | 26,00% |
| Profit (Loss) Attributable to Minority Interest | 186.000 | 209.000 | 270.000 | 29,19% |
| Earnings Per Share (Presentation) | ||||
| Basic Earnings (Loss) Per Share | 0,94 | 1,29 | 1,65 | 27,91% |
| Basic Earnings (Loss) Per Share from Discontinued Operations | 0,07 | 1,07 | 1,19 | 11,21% |
| Basic Earnings (Loss) Per Share from Continuing Operations | 0,87 | 0,22 | 0,46 | 109,09% |
| Diluted Earnings (Loss) Per Share | 0,91 | 1,25 | 1,60 | 28,00% |
| Diluted Earnings (Loss) Per Share from Discontinued Operations | 0,07 | 1,04 | 1,15 | 10,58% |
| Diluted Earnings (Loss) Per Share from Continuing Operations | 0,84 | 0,21 | 0,45 | 114,29% |
|
| ||||
| Liquidity | ||||
| Current Ratio | 73,95% | 72,15% | 68,43% | -5,44% |
| Quick Ratio / Acid Test | 47,47% | 45,26% | 41,09% | -10,14% |
| Working Capital | -3.696.000.000 | -4.252.000.000 | -4.383.000.000 | 2,99% |
| Balance ratios | ||||
| Equity Ratio | 20,70% | 22,26% | 31,48% | 29,30% |
| Debt ratios | ||||
| Debt-Asset Ratio | 79,30% | 77,74% | 68,52% | -13,46% |
| Debt to Equity Ratio | 383,13% | 349,24% | 217,61% | -60,49% |
| Profitability | ||||
| Gross Profit Margin | 0,00% | 0,00% | 0,00% | 0,00% |
| Profit Margin | 7,41% | 9,81% | 11,97% | 18,07% |
| Operating Profit Margin | 10,71% | 13,21% | 13,64% | 3,14% |
| Rate of Return | ||||
| Return on Capital Employed Ratio | 12,97% | 16,49% | 21,63% | 23,76% |
| Return on Fixed Assets | 13,10% | 15,92% | 17,52% | 9,11% |
| Return on Working Capital | -93,43% | -106,21% | -110,22% | 3,64% |